XML 19 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NON-CONTROLLING INTERESTS AND EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Redeemable Non-Controlling Interests
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-Redeemable Non-Controlling Interests
Beginning Balance at Dec. 31, 2019     $ 311            
Redeemable Non-Controlling Interests                  
Distributions to non-controlling interests     (3)            
Net income (loss)     (18)            
Ending Balance at Mar. 31, 2020     290            
Beginning balance (in shares) at Dec. 31, 2019       1,716,681          
Beginning balance at Dec. 31, 2019 $ 14,872     $ 0 $ 30,739   $ (187) $ (16,362) $ 682
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of stock options (in shares)       4,359          
Exercise of stock options 14       14        
Stock-based compensation 285       285        
Issuance of common stock for settlement of RSUs (in shares)       8,917          
Shares withheld related to net share settlement (in shares)       (107)          
Shares withheld related to net share settlement (3)       (3)        
Unrealized gain on investments in available-for-sale securities, net of tax (60)           (60)    
Foreign currency translation adjustment (148)           (148)    
Distributions to non-controlling interests (4)               (4)
Net income (loss) (2,928)             (2,936) 8
Ending balance (in shares) at Mar. 31, 2020       1,729,850          
Ending balance at Mar. 31, 2020 12,028     $ 0 31,035   (395) (19,298) 686
Beginning Balance at Dec. 31, 2019     311            
Ending Balance at Sep. 30, 2020     549            
Beginning balance (in shares) at Dec. 31, 2019       1,716,681          
Beginning balance at Dec. 31, 2019 14,872     $ 0 30,739   (187) (16,362) 682
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Unrealized gain on investments in available-for-sale securities, net of tax 10                
Foreign currency translation adjustment (268)                
Ending balance (in shares) at Sep. 30, 2020       1,760,817          
Ending balance at Sep. 30, 2020 9,633     $ 0 31,549   (445) (22,162) 691
Beginning Balance at Dec. 31, 2019     311            
Ending Balance at Dec. 31, 2020     787            
Beginning balance (in shares) at Dec. 31, 2019       1,716,681          
Beginning balance at Dec. 31, 2019 $ 14,872     $ 0 30,739   (187) (16,362) 682
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Accounting Standards Update [Extensible List] Accounting Standards Update 2020-06 [Member]                
Ending balance (in shares) at Dec. 31, 2020 1,849,794     1,849,794          
Ending balance at Dec. 31, 2020 $ 12,967 $ (243)   $ 0 35,931 $ (243) (535) (23,130) 701
Beginning Balance at Mar. 31, 2020     290            
Redeemable Non-Controlling Interests                  
Distributions to non-controlling interests     (3)            
Net income (loss)     (5)            
Ending Balance at Jun. 30, 2020     282            
Beginning balance (in shares) at Mar. 31, 2020       1,729,850          
Beginning balance at Mar. 31, 2020 12,028     $ 0 31,035   (395) (19,298) 686
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of stock options (in shares)       3,106          
Exercise of stock options 8       8        
Stock-based compensation 143       143        
Issuance of common stock under the Employee Stock Purchase Plan (in shares)       3,265          
Issuance of common stock under the Employee Stock Purchase Plan 82       82        
Issuance of common stock for settlement of RSUs (in shares)       9,778          
Shares withheld related to net share settlement (in shares)       (42)          
Shares withheld related to net share settlement (1)       (1)        
Unrealized gain on investments in available-for-sale securities, net of tax 8           8    
Foreign currency translation adjustment (257)           (257)    
Distributions to non-controlling interests (5)               (5)
Net income (loss) (1,767)             (1,775) 8
Ending balance (in shares) at Jun. 30, 2020       1,745,957          
Ending balance at Jun. 30, 2020 10,239     $ 0 31,267   (644) (21,073) 689
Redeemable Non-Controlling Interests                  
Recognition of non-controlling interest upon acquisition     290            
Distributions to non-controlling interests     (1)            
Net income (loss)     (22)            
Ending Balance at Sep. 30, 2020     549            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of stock options (in shares)       1,430          
Exercise of stock options 6       6        
Stock-based compensation 191       191        
Issuance of common stock for settlement of RSUs (in shares)       10,791          
Shares withheld related to net share settlement (in shares)       (356)          
Shares withheld related to net share settlement (11)       (11)        
Issuance of common stock as consideration for acquisitions (in shares)       2,995          
Issuance of common stock as consideration for acquisition 96       96        
Unrealized gain on investments in available-for-sale securities, net of tax 62           62    
Foreign currency translation adjustment 137           137    
Distributions to non-controlling interests (1)               (1)
Net income (loss) (1,086)             (1,089) 3
Ending balance (in shares) at Sep. 30, 2020       1,760,817          
Ending balance at Sep. 30, 2020 $ 9,633     $ 0 31,549   (445) (22,162) 691
Beginning Balance at Dec. 31, 2020     787            
Redeemable Non-Controlling Interests                  
Recognition of non-controlling interest upon acquisition     56            
Distributions to non-controlling interests     (356)            
Net income (loss)     (14)            
Ending Balance at Mar. 31, 2021     473            
Beginning balance (in shares) at Dec. 31, 2020 1,849,794     1,849,794          
Beginning balance at Dec. 31, 2020 $ 12,967 (243)   $ 0 35,931 (243) (535) (23,130) 701
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of stock options (in shares)       3,518          
Exercise of stock options 35       35        
Stock-based compensation 287       287        
Issuance of common stock for settlement of Careem Convertible Notes (in shares)       2,872          
Issuance of common stock for settlement of Careem Convertible Notes 158       158        
Issuance of common stock for settlement of RSUs (in shares)       10,924          
Shares withheld related to net share settlement (in shares)       (244)          
Shares withheld related to net share settlement (14)       (14)        
Derecognition of non-controlling interests upon divestiture (701)               (701)
Issuance of common stock as consideration for acquisitions (in shares)       505          
Issuance of common stock as consideration for acquisition 28       28        
Unrealized gain on investments in available-for-sale securities, net of tax 1,156           1,156    
Foreign currency translation adjustment 33           33    
Net income (loss) (108)             (108)  
Ending balance (in shares) at Mar. 31, 2021       1,867,369          
Ending balance at Mar. 31, 2021 $ 13,598     $ 0 36,182   654 (23,238) 0
Beginning Balance at Dec. 31, 2020     787            
Ending Balance at Sep. 30, 2021     229            
Beginning balance (in shares) at Dec. 31, 2020 1,849,794     1,849,794          
Beginning balance at Dec. 31, 2020 $ 12,967 $ (243)   $ 0 35,931 $ (243) (535) (23,130) 701
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Unrealized gain on investments in available-for-sale securities, net of tax 1,625                
Foreign currency translation adjustment $ 78                
Ending balance (in shares) at Sep. 30, 2021 1,918,591     1,918,591          
Ending balance at Sep. 30, 2021 $ 14,056     $ 0 37,281   1,168 (24,518) 125
Beginning Balance at Mar. 31, 2021     473            
Redeemable Non-Controlling Interests                  
Recognition of non-controlling interest upon acquisition     76            
Re-measurement of non-controlling interest (1,058)   1,052   (1,058)        
Net income (loss)     (32)            
Ending Balance at Jun. 30, 2021     1,569            
Beginning balance (in shares) at Mar. 31, 2021       1,867,369          
Beginning balance at Mar. 31, 2021 13,598     $ 0 36,182   654 (23,238) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of stock options (in shares)       2,454          
Exercise of stock options 40       40        
Stock-based compensation 282       282        
Reclassification of share-based award liability to additional paid-in capital 4       4        
Issuance of common stock under the Employee Stock Purchase Plan (in shares)       1,710          
Issuance of common stock under the Employee Stock Purchase Plan 67       67        
Issuance of common stock for settlement of Careem Convertible Notes (in shares)       1,352          
Issuance of common stock for settlement of Careem Convertible Notes 74       74        
Issuance of common stock for settlement of RSUs (in shares)       7,480          
Shares withheld related to net share settlement (in shares)       (55)          
Shares withheld related to net share settlement (3)       (3)        
Re-measurement of non-controlling interest (1,058)   1,052   (1,058)        
Unrealized gain on investments in available-for-sale securities, net of tax 6           6    
Foreign currency translation adjustment 21           21    
Net income (loss) 1,144             1,144  
Ending balance (in shares) at Jun. 30, 2021       1,880,310          
Ending balance at Jun. 30, 2021 14,175     $ 0 35,588   681 (22,094) 0
Redeemable Non-Controlling Interests                  
Acquisition of non-controlling interest     (1,327)            
Net income (loss)     (13)            
Ending Balance at Sep. 30, 2021     $ 229            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of stock options (in shares)       2,088          
Exercise of stock options 17       17        
Stock-based compensation 292       292        
Issuance of common stock for settlement of RSUs (in shares)       9,696          
Shares withheld related to net share settlement (in shares)       (149)          
Shares withheld related to net share settlement $ (6)       (6)        
Issuance of common stock for settlement of contingent consideration liability (in shares) 1,364                
Issuance of common stock for settlement of contingent consideration liability $ 63       63        
Issuance of restricted stock awards, subject to repurchase, in connection with acquisition of non-controlling interest (in shares)       4,641          
Recognition of non-controlling interest upon sale of Freight Holding preferred stock 125               125
Issuance of common stock as consideration for acquisitions (in shares)       20,641          
Issuance of common stock as consideration for acquisition 1,327       1,327        
Unrealized gain on investments in available-for-sale securities, net of tax 463           463    
Foreign currency translation adjustment 24           24    
Net income (loss) $ (2,424)             (2,424) 0
Ending balance (in shares) at Sep. 30, 2021 1,918,591     1,918,591          
Ending balance at Sep. 30, 2021 $ 14,056     $ 0 $ 37,281   $ 1,168 $ (24,518) $ 125